Latest News

Quanta to present interim analysis of first 255 treatments using SC+

Alcester, Warwickshire, UK, 20 September 2016:  Seroba's investee company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions for the clinic and the home, today announced that it will present a poster at a moderated session on Friday 23rd September at 11:30am-12:30pm at the 10th International...


PQ BYPASS Announces Peter Wehrly as President and CEO

Sunnyvale, Calif. and Dublin, Ireland. September 14, 2016.  Seroba's Investee Company, PQ Bypass, a medical technology company pioneering a fully percutaneous approach to femoral-popliteal bypass surgery, today announced the addition of several medical technology industry veterans to its leadership team and Board of Directors.  Most notably, Peter Wehrly has assumed the role of...


Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany.

15 September 2016, Horsham, UK and Galway, Ireland - MIMICS-3D is a prospective, multicentre, observational registry to evaluate the BioMimics 3D Self-Expanding Stent System in the treatment of peripheral arterial disease.  The Registry will evaluate safety, effectiveness and device performance within a real-world clinical population in a minimum of 500 patients across. ...


< back to home page